Product Information
COLESEVELAM HCL 3.75 G PACKET is a generic product labeled by Ascend Laboratories, LLC, priced at $2.7042 per EA under NDC 67877052330. Its NADAC has been published 361 times since Nov 6, 2019.
FDA first approved this application on May 6, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3.75 g/1
Manufacturer
Ascend Laboratories, LLCNDC
67877052330
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
COLESEVELAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210316FDA Approved
5/6/2019
TE Code
AB
On Market Since
5/9/2019
Pharmacological Classes
Price Statistics
The NADAC for COLESEVELAM HCL 3.75 G PACKET has been published 361 times since Nov 6, 2019, and over the history we have for it it has declined 79.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7042 per EA |
|---|---|
| All-time high | $13.4431 (Jan 15, 2020) |
| All-time low | $2.4176 (May 20, 2026) |
| 52-week high | $2.7662 |
| 52-week low | $2.4176 |
| Median price | $3.8632 |
| Average price | $5.6022 |
| Largest weekly change | +44.2% (Feb 23, 2022) |
| Weeks tracked | 361 |
| Tracking since | Nov 6, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Colesevelam hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Colesevelam hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid Sequestrant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COLESEVELAM HCL 3.75 G PACKET?
The current National Average Drug Acquisition Cost (NADAC) for COLESEVELAM HCL 3.75 G PACKET, manufactured by Ascend Laboratories, LLC, is $2.7042 per EA (NDC 67877052330), effective Sep 30, 2026.
How has the price of COLESEVELAM HCL 3.75 G PACKET changed over time?
Over the history we have for it, the NADAC for COLESEVELAM HCL 3.75 G PACKET has declined 79.6%. It has been tracked across 361 weekly CMS publications since Nov 6, 2019.
What are the highest and lowest recorded NADAC prices for COLESEVELAM HCL 3.75 G PACKET?
Since Nov 6, 2019, the NADAC for COLESEVELAM HCL 3.75 G PACKET has ranged from a low of $2.4176 (May 20, 2026) to a high of $13.4431 (Jan 15, 2020), with a median of $3.8632 per EA.
Are there cheaper alternatives to COLESEVELAM HCL 3.75 G PACKET?
No other NADAC-published product currently shares the active ingredient and strength of COLESEVELAM HCL 3.75 G PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COLESEVELAM HCL 3.75 G PACKET?
COLESEVELAM HCL 3.75 G PACKET (NDC 67877052330) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.